These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31902521)

  • 21. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamate-glutamine and GABA in brain of normal aged and patients with cognitive impairment.
    Huang D; Liu D; Yin J; Qian T; Shrestha S; Ni H
    Eur Radiol; 2017 Jul; 27(7):2698-2705. PubMed ID: 27966041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
    Suriyajakryuththana W; Tuntiyatorn L; Teepprasarn N; Sukying C
    J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.
    Mandal PK; Saharan S; Tripathi M; Murari G
    Biol Psychiatry; 2015 Nov; 78(10):702-10. PubMed ID: 26003861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
    Guo Z; Liu X; Hou H; Wei F; Chen X; Shen Y; Chen W
    Compr Psychiatry; 2016 Aug; 69():179-85. PubMed ID: 27423359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.
    Catani M; Mecocci P; Tarducci R; Howard R; Pelliccioli GP; Mariani E; Metastasio A; Benedetti C; Senin U; Cherubini A
    J Am Geriatr Soc; 2002 Oct; 50(10):1707-10. PubMed ID: 12366626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease: An in vivo MRS Study.
    Shukla D; Mandal PK; Mishra R; Punjabi K; Dwivedi D; Tripathi M; Badhautia V
    J Alzheimers Dis; 2021; 84(3):1139-1152. PubMed ID: 34633325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.
    Catani M; Cherubini A; Howard R; Tarducci R; Pelliccioli GP; Piccirilli M; Gobbi G; Senin U; Mecocci P
    Neuroreport; 2001 Aug; 12(11):2315-7. PubMed ID: 11496102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
    Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
    Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    Wang H; Tan L; Wang HF; Liu Y; Yin RH; Wang WY; Chang XL; Jiang T; Yu JT
    J Alzheimers Dis; 2015; 46(4):1049-70. PubMed ID: 26402632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton magnetic resonance spectroscopy with dementia.
    Shiino A; Matsuda M; Morikawa S; Inubushi T; Akiguchi I; Handa J
    Surg Neurol; 1993 Feb; 39(2):143-7. PubMed ID: 8394604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B
    Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down syndrome with and without dementia: an in vivo proton Magnetic Resonance Spectroscopy study with implications for Alzheimer's disease.
    Lamar M; Foy CML; Beacher F; Daly E; Poppe M; Archer N; Prasher V; Murphy KC; Morris RG; Simmons A; Lovestone S; Murphy DGM
    Neuroimage; 2011 Jul; 57(1):63-68. PubMed ID: 21504795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging.
    Parnetti L; Tarducci R; Presciutti O; Lowenthal DT; Pippi M; Palumbo B; Gobbi G; Pelliccioli GP; Senin U
    Mech Ageing Dev; 1997 Jul; 97(1):9-14. PubMed ID: 9223122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents.
    Calderón-Garcidueñas L; Mora-Tiscareño A; Melo-Sánchez G; Rodríguez-Díaz J; Torres-Jardón R; Styner M; Mukherjee PS; Lin W; Jewells V
    J Alzheimers Dis; 2015; 48(4):1065-75. PubMed ID: 26402110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain metabolism in Alzheimer disease and vascular dementia assessed by in vivo proton magnetic resonance spectroscopy.
    Herminghaus S; Frölich L; Gorriz C; Pilatus U; Dierks T; Wittsack HJ; Lanfermann H; Maurer K; Zanella FE
    Psychiatry Res; 2003 Jul; 123(3):183-90. PubMed ID: 12928106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.
    Ernst T; Chang L; Melchor R; Mehringer CM
    Radiology; 1997 Jun; 203(3):829-36. PubMed ID: 9169712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.